Oruka Therapeutics, Inc. Amortization of Deferred Charges
Oruka Therapeutics, Inc. (ORKA) reported Amortization of Deferred Charges of $189.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-17.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfDeferredCharges · last filed 2016-03-17
- Oruka Therapeutics, Inc. amortization of deferred charges for the quarter ending 2015-12-31 was $56.00K, a 69.70% increase year-over-year.
- Oruka Therapeutics, Inc. amortization of deferred charges for the quarter ending 2015-09-30 was $55.00K.
- Oruka Therapeutics, Inc. amortization of deferred charges for the quarter ending 2015-06-30 was $47.00K.
- Oruka Therapeutics, Inc. amortization of deferred charges for the quarter ending 2015-03-31 was $31.00K.
- Oruka Therapeutics, Inc. amortization of deferred charges for fiscal 2015 was $189.00K, a 182.09% increase from fiscal 2014.
- Oruka Therapeutics, Inc. amortization of deferred charges for fiscal 2014 was $67.00K.
| Period end | Amortization of Deferred Charges 3 month | Amortization of Deferred Charges 6 month | Amortization of Deferred Charges 9 month | Amortization of Deferred Charges 12 month |
|---|---|---|---|---|
| 2015-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-17 | $111.00K derived: sum of 2 quarters · filed 2016-03-17 | $158.00K derived: sum of 3 quarters · filed 2016-03-17 | $189.00K 10-K · filed 2016-03-17 |
| 2015-09-30 | $55.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $102.00K derived: sum of 2 quarters · filed 2015-11-12 | $133.00K 10-Q · filed 2015-11-12 | $166.00K derived: sum of 4 quarters · filed 2016-03-17 |
| 2015-06-30 | $47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | $78.00K 10-Q · filed 2015-08-11 | $111.00K derived: sum of 3 quarters · filed 2016-03-17 | |
| 2015-03-31 | $31.00K 10-Q · filed 2015-05-12 | $64.00K derived: sum of 2 quarters · filed 2016-03-17 | ||
| 2014-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-17 | $67.00K 10-K · filed 2016-03-17 | ||
| 2014-09-30 | $34.00K 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Veradermics, Inc (MANE) | United States | $4.839B |